Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression

被引:157
作者
Asanuma, H
Sharp, M
Maecker, HT
Maino, VC
Arvin, AM
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Becton Disckinson Immunocytometry Syst, San Jose, CA USA
关键词
D O I
10.1086/315347
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Memory T cells specific for varicella-zoster virus (VZV), herpes simplex virus (HSV), and human cytomegalovirus (HCMV) were compared in immune adults by intracellular cytokine (ICC) detection. The mean percentages of CD4(+) T cells were 0.11% for VZV and 0.22% for HSV by interferon (IFN)-gamma production; the frequency for HCMV was significantly higher at 1.21%, Percentages of VZV-, HSV-, and HCMV-specific CD4(+) T cells were similar by use of tumor necrosis factor (TNF)-alpha. HCMV-stimulated CD8(+) T cells produced IFN-gamma (1.11%) and TNF-alpha (1.71%); VZV- and HSV-specific CD8(+) T cells were not detectable. VZV CD4(+) T cell numbers were similar in young adults with natural or vaccine-induced immunity. VZV CD4(+) T cells were significantly less frequent in older adults. Secondary varicella immunization did not increase VZV-specific CD4(+) T cell frequencies by ICC assay, Numbers of memory T cells specific for herpesviruses may vary with sites of viral latency and with hose age.
引用
收藏
页码:859 / 866
页数:8
相关论文
共 35 条
[1]  
ARVIN AM, 1991, J IMMUNOL, V146, P257
[2]   Immune responses to varicella-zoster virus [J].
Arvin, AM .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1996, 10 (03) :529-&
[3]   EARLY IMMUNE-RESPONSE IN HEALTHY AND IMMUNOCOMPROMISED SUBJECTS WITH PRIMARY VARICELLA-ZOSTER VIRUS-INFECTION [J].
ARVIN, AM ;
KOROPCHAK, CM ;
WILLIAMS, BRG ;
GRUMET, FC ;
FOUNG, SKH .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (03) :422-429
[4]   Live attenuated varicella vaccine [J].
Arvin, AM ;
Gershon, AA .
ANNUAL REVIEW OF MICROBIOLOGY, 1996, 50 :59-100
[5]  
ARVIN AM, 1995, VIROLOGY, P2547
[6]   THE IMMUNOGENICITY OF THE OKA MERCK VARICELLA VACCINE IN RELATION TO INFECTIOUS VARICELLA-ZOSTER VIRUS AND RELATIVE VIRAL-ANTIGEN CONTENT [J].
BERGEN, RE ;
DIAZ, PS ;
ARVIN, AM .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1049-1054
[7]   A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older [J].
Berger, R ;
Trannoy, E ;
Holländer, G ;
Bailleux, F ;
Rudin, C ;
Creusvaux, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 :S99-S103
[8]   VARICELLA-ZOSTER VIRUS (VZV) SPECIFIC CYTOTOXICITY AFTER IMMUNIZATION OF NONIMMUNE ADULTS WITH OKA STRAIN ATTENUATED VZV VACCINE [J].
HAYWARD, A ;
VILLANUEBA, E ;
COSYNS, M ;
LEVIN, M .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :260-264
[9]  
HAYWARD AR, 1984, J IMMUNOL, V133, P2469
[10]   LYMPHOCYTE-RESPONSES TO VARICELLA ZOSTER VIRUS IN THE ELDERLY [J].
HAYWARD, AR ;
HERBERGER, M .
JOURNAL OF CLINICAL IMMUNOLOGY, 1987, 7 (02) :174-178